Suzhou, China

Lingjiao Tang

This inventor holds 1 USPTO granted patent. Top assignees: Tongli Biomedical Co., Ltd., Zhejiang University. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lingjiao Tang: Innovator in Chemical Synthesis

Introduction

Lingjiao Tang is a notable inventor based in Suzhou, China. He has made significant contributions to the field of chemical synthesis, particularly in the preparation of complex organic compounds. His innovative methods have implications for pharmaceutical development and enzyme utilization.

Latest Patents

Lingjiao Tang holds a patent for the "Preparation method for (R)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, derivatives thereof and levo-praziquantel." This patent describes a method that utilizes a racemate of ester as a substrate, catalyzed by immobilized lipase in a circulating fluidized bed reactor. The process enhances enzyme utilization and reduces the enzyme/substrate ratio, all while maintaining mild reaction conditions and high stereoselectivity.

Career Highlights

Throughout his career, Lingjiao Tang has worked with prominent organizations such as Tongli Biomedical Co., Ltd. and Zhejiang University. His experience in these institutions has allowed him to refine his skills and contribute to advancements in chemical synthesis.

Collaborations

Lingjiao Tang has collaborated with esteemed colleagues, including Jianping Wu and Lirong Yang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Lingjiao Tang's work exemplifies the intersection of innovation and practical application in the field of chemistry. His contributions continue to influence the development of new methods in organic synthesis, showcasing the importance of inventive thinking in scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…